Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 10;38(20):2310-2320.
doi: 10.1200/JCO.19.02905. Epub 2020 May 22.

Molecular Predictive and Prognostic Markers in Locoregional Management

Eleftherios P Mamounas  1 , Melissa P Mitchell  2 , Wendy A Woodward  2
Affiliations
Review

Molecular Predictive and Prognostic Markers in Locoregional Management

Eleftherios P Mamounas et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Molecular Predictive and Prognostic Markers in Locoregional Management

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Eleftherios P. Mamounas

Honoraria: Genentech, Genomic Health

Consulting or Advisory Role: Genomic Health, bioTheranostics, Genentech, Merck, Daiichi Sankyo

Speakers' Bureau: Genomic Health, Genentech

Travel, Accommodations, Expenses: Genomic Health, Genentech

Wendy A. Woodward

Consulting or Advisory Role: Genomic Health, Epic Sciences

No other potential conflicts of interest were reported.

References

    1. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 9810869–108742001 - PMC - PubMed
    1. van de Vijver MJ, He YD, van’t Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 3471999–20092002 - PubMed
    1. van ’t Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer Nature 415530–5362002 - PubMed
    1. Foekens JA, Atkins D, Zhang Y, et al. Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer J Clin Oncol 241665–16712006 - PubMed
    1. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 3512817–28262004 - PubMed